Intelligent Bio Solutions Inc (NASDAQ:INBS) does about 1.59M shares in volume on a normal day but saw 4339006 shares change hands in the recent trading day. The company now has a market cap of 6.15M USD. Its current market price is $1.97, marking an increase of 10.06% compared to the previous close of $1.79. The 52 week high reached by this stock is $21.60 whilst the lowest price level in 52 weeks is $1.00.
Intelligent Bio Solutions Inc (INBS) has a 20-day trading average at $1.3010 and the current price is -90.88% off the 52-week high compared with 97.00% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.4458 and its 200-day simple moving average is $2.9175. If we look at the stock’s price movements over the week, volatility stands at 27.98%, which decreases to 16.28% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 74.96 to suggest the stock is overbought.
The consensus objective for the share price is $12.00, suggesting that the stock has a potential upside of 83.58% over the period.
The current price level is 56.23%, 36.35%, and -32.61% away from its SMA20, SMA50, and SMA200 respectively, with the INBS price moving below the 50-day SMA on current market day. Intelligent Bio Solutions Inc (INBS) stock is up 48.12% over the week and 75.89% over the past month. Its price is -51.42% year-to-date and -89.80% over the past year.
The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -24.36 above consensus estimates by 0.48. The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year. Expected sales for next quarter are $1.75M, which analysts say will come at $4.18M for the current fiscal year and next year at $11.62M. In addition, estimates put the company’s current quarterly revenue at an average of $1.43M.
To reach the target analysts have set, the stock logically needs to grow 83.58 percent from here.
Outstanding shares total 3.12M with insiders holding 1.46% of the shares and institutional holders owning 12.99% of the company’s common stock. The company has a return on investment of -87.71% and return on equity of -116.92%. The beta has a value of 4.47. Price to book ratio is 0.52 and price to sales ratio is 2.17.
